• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Shares of Brazilian companies are trading lower amid the beginning of Lula's presidential term. Lula has taken steps to withdraw the privatization process for multiple state-owned companies.

    1/3/23 11:39:58 AM ET
    $ABEV
    $AZUL
    $BBD
    $BSBR
    Beverages (Production/Distribution)
    Consumer Staples
    Air Freight/Delivery Services
    Consumer Discretionary
    Get the next $ABEV alert in real time by email
    Shares of Brazilian companies are trading lower amid the beginning of Lula's presidential term. Lula has taken steps to withdraw the privatization process for multiple state-owned companies.
    Get the next $ABEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABEV
    $AZUL
    $BBD
    $BSBR

    CompanyDatePrice TargetRatingAnalyst
    VALE S.A.
    $VALE
    4/20/2026$17.00Overweight → Equal Weight
    Barclays
    Ambev S.A.
    $ABEV
    4/16/2026$2.65Neutral → Sell
    UBS
    Ultrapar Participacoes S.A. (New)
    $UGP
    4/8/2026$6.00Buy → Hold
    HSBC Securities
    VALE S.A.
    $VALE
    4/3/2026$19.00Neutral → Buy
    BofA Securities
    VALE S.A.
    $VALE
    4/2/2026$19.00Neutral → Buy
    BofA Securities
    Gerdau S.A.
    $GGB
    4/1/2026$4.59Market Perform → Outperform
    Itau BBA
    Edwards Lifesciences Corporation
    $EW
    4/1/2026$92.00Peer Perform → Outperform
    Wolfe Research
    Ultrapar Participacoes S.A. (New)
    $UGP
    3/13/2026$5.60Underperform → Hold
    Jefferies
    More analyst ratings

    $ABEV
    $AZUL
    $BBD
    $BSBR
    SEC Filings

    View All

    SEC Form 6-K filed by Gerdau S.A.

    6-K - GERDAU S.A. (0001073404) (Filer)

    4/16/26 4:48:14 PM ET
    $GGB
    Steel/Iron Ore
    Industrials

    SEC Form 6-K filed by Ultrapar Participacoes S.A. (New)

    6-K - ULTRAPAR HOLDINGS INC (0001094972) (Filer)

    4/16/26 6:03:28 AM ET
    $UGP
    Oil/Gas Transmission
    Utilities

    SEC Form 6-K filed by VALE S.A.

    6-K - Vale S.A. (0000917851) (Filer)

    4/15/26 8:42:00 AM ET
    $VALE
    Metal Mining
    Basic Materials

    $ABEV
    $AZUL
    $BBD
    $BSBR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Merlin Names Board of Directors Including Former Secretary of the Navy, Amazon's First Chief Accounting Officer, and Former Blue Origin CEO

    BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Merlin, Inc. (NASDAQ:MRLN), an aerospace and defense technology company building the operating system of record for autonomous flight, today announced the composition of its Board of Directors following the closing of Merlin Labs, Inc.'s business combination with Inflection Point Acquisition Corp. IV and the commencement of trading on the Nasdaq Global Market on March 17, 2026. The Board is composed of seven directors, including founder and CEO Matt George as Chairman, and six directors determined to be independent under Nasdaq listing rules. "Each of our directors brings a distinct and complementary perspective, from serving as Secretary of the

    4/16/26 10:04:28 AM ET
    $AZUL
    $CVEO
    $LUNR
    Air Freight/Delivery Services
    Consumer Discretionary
    Hotels/Resorts
    Industrial Machinery/Components

    Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026

    Edwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended March 31, 2026 after the market closes on Thursday April 23, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the "Investor Relations" section of the Edwards website at ir.edwards.com. About Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and heal

    4/16/26 7:05:00 AM ET
    $EW
    Industrial Specialties
    Health Care

    Azul Files 20-F Annual Report for Fiscal Year 2025 in the U.S.

    SÃO PAULO, April 10, 2026 /PRNewswire/ -- Azul Brazilian Airlines ((B3:AZUL53, OTC:AZLUY) announces that it filed its Form 20-F annual report for fiscal year 2025 with the U.S. Securities and Exchange Commission (SEC) on April 2nd, 2026. The report is available on the SEC's website at www.sec.gov and on Azul's Investor Relations website at ri.voeazul.com.br. Azul's shareholders and holders of American depositary shares can also request the document from Azul's Investor Relations department.About Azul  Azul S.A. ((B3: AZUL53, OTC:AZULQ), the largest airline in Brazil in terms of cities served, offers more than 800 daily flights to 137 destinations. With an operational fleet of around 200 airc

    4/10/26 2:00:00 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    $ABEV
    $AZUL
    $BBD
    $BSBR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vale S.A. downgraded by Barclays with a new price target

    Barclays downgraded Vale S.A. from Overweight to Equal Weight and set a new price target of $17.00

    4/20/26 8:25:38 AM ET
    $VALE
    Metal Mining
    Basic Materials

    AmBev downgraded by UBS with a new price target

    UBS downgraded AmBev from Neutral to Sell and set a new price target of $2.65

    4/16/26 8:00:07 AM ET
    $ABEV
    Beverages (Production/Distribution)
    Consumer Staples

    Ultrapar Participacoes downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Ultrapar Participacoes from Buy to Hold and set a new price target of $6.00

    4/8/26 8:30:36 AM ET
    $UGP
    Oil/Gas Transmission
    Utilities

    $ABEV
    $AZUL
    $BBD
    $BSBR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Guillinet Fajerman Sergio

    4 - Itau Unibanco Holding S.A. (0001132597) (Issuer)

    4/20/26 5:30:51 PM ET
    $ITUB
    Major Banks
    Finance

    SEC Form 4 filed by Guillinet Fajerman Sergio

    4 - Itau Unibanco Holding S.A. (0001132597) (Issuer)

    4/17/26 10:42:38 AM ET
    $ITUB
    Major Banks
    Finance

    SEC Form 4 filed by Garrido Eduardo Alvarez

    4 - Banco Santander (Brasil) S.A. (0001471055) (Issuer)

    4/16/26 6:33:22 PM ET
    $BSBR
    Commercial Banks
    Finance

    $ABEV
    $AZUL
    $BBD
    $BSBR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Zovighian Bernard J covered exercise/tax liability with 4,245 shares, converted options into 6,265 shares and bought $49,753 worth of shares (580 units at $85.74), increasing direct ownership by 5% to 46,836 units (SEC Form 4)

    4 - Edwards Lifesciences Corp (0001099800) (Issuer)

    5/7/24 5:53:27 PM ET
    $EW
    Industrial Specialties
    Health Care

    $ABEV
    $AZUL
    $BBD
    $BSBR
    Leadership Updates

    Live Leadership Updates

    View All

    UATP Appoints David Newington to Lead Asia-Pacific Commercial Team

    SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- UATP, the global network enabling organizations to simplify payment processes and expand their payment capabilities, announced today the appointment of David Newington as Managing Director, Commercial, Asia-Pacific, effective immediately. With more than 25 years of leadership experience spanning Payments, IT, and Corporate Travel, Newington brings a proven track record of driving growth, building high-performing teams, and delivering customer-centric solutions across Australia, the United States, and Singapore. In this role, Newington w

    12/17/25 8:00:00 AM ET
    $AAL
    $DAL
    $GOL
    Air Freight/Delivery Services
    Consumer Discretionary

    Edwards Lifesciences Announces CFO Transition Plan

    Edwards Lifesciences (NYSE:EW) today announced that Scott Ullem, the company's chief financial officer, has decided to transition from his role by midyear 2026. While the company initiates a selection process to appoint a new CFO, this planned transition will enable continuity and a smooth transfer of responsibilities. Following the appointment of a new CFO, Ullem will continue in an advisory role. About Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are insp

    10/30/25 4:15:00 PM ET
    $EW
    Industrial Specialties
    Health Care

    Incorporation of GLAI and GIB into GLA and future delisting from Level 2

    SÃO PAULO, Oct. 13, 2025 /PRNewswire/ -- GOL Linhas Aéreas Inteligentes S.A. (B3: GOLL54) ("GOL" or "Company"), one of the main airlines in Brazil, in compliance with article 157, paragraph 4, of Law No. 6,404/76 and the Resolution of the Brazilian Securities and Exchange Commission No. 44/2021 ("Resolution CVM 44"), hereby informs its shareholders and the market in general that, on this date, the Company's Board of Directors approved, among other matters, the convening of General Meetings to deliberate on the proposed merger of the Company and Gol Investment Brasil S.A., a privately held corporation registered with the CNPJ/MF under No. 55.012.370/0001-30 ("GIB"), into Gol Linhas Aéreas S.A

    10/13/25 10:37:00 PM ET
    $GOL
    Air Freight/Delivery Services
    Consumer Discretionary

    $ABEV
    $AZUL
    $BBD
    $BSBR
    Financials

    Live finance-specific insights

    View All

    Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026

    Edwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended March 31, 2026 after the market closes on Thursday April 23, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the "Investor Relations" section of the Edwards website at ir.edwards.com. About Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and heal

    4/16/26 7:05:00 AM ET
    $EW
    Industrial Specialties
    Health Care

    GERDAU S.A. - CONSOLIDATED INFORMATION

    SÃO PAULO, Feb. 23, 2026 /PRNewswire/ -- 4Q25 Highlights Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of R$2.4 billion in 4Q25, 13% lower than in 3Q25 and in line with 4Q24. Notably, North America accounted for 62% of the Company's Consolidated EBITDA in 2025.Investments (CAPEX) of R$1.5 billion in 4Q25, totaling R$6.1 billion in 2025. For 2026, the approved investment plan projects R$ 4.7 billion in CAPEX.Dividend distribution of R$0.10 per share, equivalent to R$197.5 million, to be paid based on March 18, 2026. In 2025, Gerdau S.A. distributed R$2.4 billion to shareholders through dividend and share buybacks, reaching a 182.3% shareholder return.The Com

    2/23/26 5:10:00 PM ET
    $GGB
    Steel/Iron Ore
    Industrials

    Edwards Lifesciences Reports Fourth Quarter Results

    Edwards Lifesciences (NYSE:EW) today reported financial results for the quarter and full-year ended Dec. 31, 2025. Highlights and Outlook Q4 sales grew 13.3% to $1.57 billion1, constant currency2 sales grew 11.6% Q4 TAVR sales grew 12.0% to $1.16 billion1; constant currency2 sales grew 10.6% Q4 TMTT sales grew more than 40% to $156 million1 from repair and replacement therapies Q4 EPS of $0.111; adjusted2 EPS of $0.58 FY 2025 sales grew 11.5%, 10.7% constant currency2 Increased confidence in FY 2026 constant currency2 sales growth of 8 – 10% FY 2026 revenue outlook includes TMTT growing 35 – 45% to $740 – $780 million Increased confidence in FY 2026 adjusted2 EPS $

    2/10/26 4:15:00 PM ET
    $EW
    Industrial Specialties
    Health Care

    $ABEV
    $AZUL
    $BBD
    $BSBR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Azul S.A.

    SC 13G - AZUL SA (0001432364) (Subject)

    12/6/24 4:26:59 PM ET
    $AZUL
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form SC 13G filed by Gerdau S.A.

    SC 13G - GERDAU S.A. (0001073404) (Subject)

    11/12/24 9:55:15 AM ET
    $GGB
    Steel/Iron Ore
    Industrials

    SEC Form SC 13G filed by Edwards Lifesciences Corporation

    SC 13G - Edwards Lifesciences Corp (0001099800) (Subject)

    11/8/24 10:34:33 AM ET
    $EW
    Industrial Specialties
    Health Care